Bitter pill for Ranbaxy: SC notice on quality concerns

PIL also seeks action against drug regulator for letting a FDA-censured firm continue operations

pankaj

Pankaj Kumar | March 14, 2014



Ranbaxy faced another setback on Friday as the supreme court issued notice to the leading drugmaker as well as the central government following a PIL that seeks cancellation of the firm’s licence and a CBI probe into the allegedly sub-standard quality of its medicines.

"The matter requires consideration and we will examine it but we cannot grant any interim stay," a bench headed by chief justice P Sathasivam said.

The PIL was filed by advocate ML Sharma, pointing out that Ranbaxy was fined $500 million by the US Food and Drug Administration (USFDA) for making and selling adulterated drugs last year. The PIL demanded court to stop production from the manufacturing units in Paonta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh.

Read more about Ranbaxy’s travails:

Dirty medicine: Ranbaxy's FDA travails



Sharma sought action against the drug regulator, Central Drug Standards Control Organisation (CDSCO), for granting permission to Ranbaxy to sell drugs in India though the firm has faced a series of strictures from the US FDA.

Read interview with drug controller GN Singh:

"Ranbaxy has been asked to comply with regulations"

Comments

 

Other News

Ram Nath Kovind to be India’s next president

 India’s 14th president is going to be former Bihar governor Ram Nath Kovind, a dalit. He triumphed over former Lok Sabha speaker Meira Kumar in the vote count that took place on Thursday.   Kovind succeeds Pranab Mukherjee, who demits office on July 25. He becomes the

At JNU, all that is beautiful and “solid has melted into the air”…

Dear “Professor” Vice Chancellor,    When the clamour is made all around us, and rightly so, about the condition of growing degeneration of quality education in the higher institutions of learning in our country, you have justly – for which you must be

Making words count

In 2016, 38 bills were enacted in parliament. During that year, on average, the time spent on legislative debate (without interruptions) was 23 percent in the Lok Sabha and 16 percent in the Rajya Sabha (calculated from the PRS Legislative Research data).  Time is, however, just one measure

Business goes north

Tyre manufacturer MRF (originally Madras Rubber Factory), which enjoys instant brand recall thanks to the presence of its logo on cricket superstar Virat Kohli’s bat, figures among the most prominent industries in Tamil Nadu. But the state does not figure in its future plans. Like another TN industry

Do you think the Central Water Commission needs to take on the responsibility of irrigation governance?

Do you think the Central Water Commission needs to take on the responsibility of irrigation governance?

Debating the idea of privacy

Is right to privacy a fundamental right? The Supreme Court on Wednesday heard arguments on the contentious issue linked to the Aadhaar debate. Here`s how the issue has been addressed by different countries, with the first reference dating to 1890.   The Supreme Court on Tuesday s





Video

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter